Reduced SKP1 and CUL1 expression underlies increases in Cyclin E1 and chromosome instability in cellular precursors of high-grade serous ovarian cancer

Br J Cancer. 2021 May;124(10):1699-1710. doi: 10.1038/s41416-021-01317-w. Epub 2021 Mar 17.

Abstract

Background: High-grade serous ovarian cancer (HGSOC) is the most common and lethal ovarian cancer histotype. Chromosome instability (CIN, an increased rate of chromosome gains and losses) is believed to play a fundamental role in the development and evolution of HGSOC. Importantly, overexpression of Cyclin E1 protein induces CIN, and genomic amplification of CCNE1 contributes to HGSOC pathogenesis in ~20% of patients. Cyclin E1 levels are normally regulated in a cell cycle-dependent manner by the SCF (SKP1-CUL1-FBOX) complex, an E3 ubiquitin ligase that includes the proteins SKP1 and CUL1. Conceptually, diminished SKP1 or CUL1 expression is predicted to underlie increases in Cyclin E1 levels and induce CIN.

Methods: This study employs fallopian tube secretory epithelial cell models to evaluate the impact diminished SKP1 or CUL1 expression has on Cyclin E1 and CIN in both short-term (siRNA) and long-term (CRISPR/Cas9) studies.

Results: Single-cell quantitative imaging microscopy approaches revealed changes in CIN-associated phenotypes and chromosome numbers and increased Cyclin E1 in response to diminished SKP1 or CUL1 expression.

Conclusions: These data identify SKP1 and CUL1 as novel CIN genes in HGSOC precursor cells that may drive early aetiological events contributing to HGSOC development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism
  • Chromosomal Instability / genetics*
  • Cullin Proteins / genetics
  • Cullin Proteins / metabolism
  • Cyclin E / genetics
  • Cyclin E / metabolism
  • Cystadenocarcinoma, Serous* / genetics
  • Cystadenocarcinoma, Serous* / pathology
  • Female
  • Gene Expression Regulation, Neoplastic / physiology
  • Humans
  • Neoplasm Grading
  • Neoplastic Stem Cells / metabolism*
  • Neoplastic Stem Cells / pathology
  • Oncogene Proteins / genetics
  • Oncogene Proteins / metabolism
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / pathology
  • S-Phase Kinase-Associated Proteins / genetics
  • S-Phase Kinase-Associated Proteins / metabolism
  • Tumor Cells, Cultured

Substances

  • CCNE1 protein, human
  • Cullin 1
  • Cullin Proteins
  • Cyclin E
  • Oncogene Proteins
  • S-Phase Kinase-Associated Proteins
  • SKP1 protein, human

Grants and funding